TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action

Cancer immunotherapy has produced impressive clinical results in recent years. Despite the success of the checkpoint blockade strategies targeting cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death receptor 1 (PD-1), a large portion of cancer patients have not yet benefited from this nov...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Wenwen, Yang, Min, Turner, Abbey, Xu, Chunling, Ferris, Robert L., Huang, Jianan, Kane, Lawrence P., Lu, Binfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372657/
https://www.ncbi.nlm.nih.gov/pubmed/28300768
http://dx.doi.org/10.3390/ijms18030645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372657/
https://www.ncbi.nlm.nih.gov/pubmed/28300768
http://dx.doi.org/10.3390/ijms18030645

Ejemplares similares